Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ACRO BIOMEDICAL CO., LTD. | acbm_10k.htm |
| EX-31.1 - EX-31.1 - ACRO BIOMEDICAL CO., LTD. | acbm_ex311.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-K for the year ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Pao-Chi Chu, chief executive officer of the Company, and acting chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January 7, 2020 | By: | /s/ Pao-Chi Chu | |
| Pao-Chi Chu | ||
| Chief Executive Officer and Chief Financial Officer | ||
|
| (Principal Executive, Financial and Accounting Officer) |